Model Number 8637-40 |
Device Problem
Failure to Interrogate (1332)
|
Patient Problem
No Known Impact Or Consequence To Patient (2692)
|
Event Date 03/01/2017 |
Event Type
Injury
|
Event Description
|
Information was received from a healthcare professional (hcp) and a manufacturer's representative (rep) regarding a patient receiving 2,000 mcg/ml baclofen at a dose of 115 mcg/day and 20 mg/ml morphine at a dose of 1.15 mg/day via an implantable infusion pump for intractable spasticity and multiple sclerosis.It was reported that the hcp had a telemetry problem with their clinician programmer.The hcp tried to interrogate the pump but was unable to complete telemetry.As troubleshooting the hcp tried different positions and removed electronics devices from the room, there were no more cell rooms in the room.The hcp tried unplugging the ultrasound machine and unplugging the power running to the bed which did not resolve the issue.The pump was not flipped and was refilled on (b)(6) 2017.Using a different clinician programmer did not resolve the issue.The clinician programmers that were used had been used successfully before in the same room to interrogate other pumps.No symptoms were reported.The hcp brought the patient outside and were still unable to read the pump.It was reported that on (b)(6) 2017 the rep talked to the hcp who stated that the patient used a personal therapy manager (ptm) programmer that also was not communicating successfully to the pump.The rep reported that the patient had not had any trauma to the pump or medical procedures that possibly the pump was exposed to.
|
|
Event Description
|
Additional information was received from a healthcare professional (hcp) on 2017-mar-06.It was reported that the plan was to have a local manufacturer's representative (rep) meet with the patient to see if the rep could interrogate the pump with a different programmer.The hcp was "very uncomfortable sitting on this, and was eager to have something clarified or fixed soon.".
|
|
Manufacturer Narrative
|
A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Additional information was received from a manufacturer's representative (rep) on 2017-mar-22.It was reported by the rep that they were still unable to establish telemetry with this pump using a clinician programmer as of (b)(6) 2017.They attempted using multiple programmers.Rep stated that "there was nothing wrong" with therapy and patient was doing fine medically as far as the rep knew.It was reviewed that the healthcare professional (hcp) should consider replacing the pump and the rep was to relay that information to the hcp.
|
|
Manufacturer Narrative
|
A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Additional information was received from a healthcare professional (hcp) on 2017-apr-03.It was reported that the patient's weight was (b)(6) lbs at the time of the event.
|
|
Event Description
|
Additional information was received from a manufacturer's representative (rep) on (b)(6) 2017.It was reported that the pump was going to be replaced on (b)(6) 2017.The pump was to be returned to the manufacturer for analysis.No further complications were expected or anticipated.
|
|
Manufacturer Narrative
|
Interrogation of implantable pump serial number (b)(4) revealed the device had been programmed to deliver 2,000 mcg/ml of lioresal at 114.9 mcg/day and 20 mg/ml of morphine at 1.149 mg/day via the simple continuous infusion mode.Evaluation of the device revealed the following: analysis identified a bit flip in the telemetry handler memory (circuit board) which resulted in inconsistent telemetry.Eval code-conclusion (b)(4) has been updated to eval code-conclusion (b)(4).This device issue is known and documented in the labeling per (b)(4) ¿ n¿vision clinician programmer with software synchromed ii infusion systems.If information is provided in the future, a supplemental report will be issued.
|
|
Manufacturer Narrative
|
Corrected information: sex, date of birth.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|